1. Home
  2. BBIO vs FSS Comparison

BBIO vs FSS Comparison

Compare BBIO & FSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • FSS
  • Stock Information
  • Founded
  • BBIO 2015
  • FSS 1901
  • Country
  • BBIO United States
  • FSS United States
  • Employees
  • BBIO N/A
  • FSS N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • FSS Auto Manufacturing
  • Sector
  • BBIO Health Care
  • FSS Consumer Discretionary
  • Exchange
  • BBIO Nasdaq
  • FSS Nasdaq
  • Market Cap
  • BBIO 9.4B
  • FSS 7.8B
  • IPO Year
  • BBIO 2019
  • FSS N/A
  • Fundamental
  • Price
  • BBIO $51.21
  • FSS $125.60
  • Analyst Decision
  • BBIO Strong Buy
  • FSS Hold
  • Analyst Count
  • BBIO 16
  • FSS 4
  • Target Price
  • BBIO $64.44
  • FSS $127.33
  • AVG Volume (30 Days)
  • BBIO 2.2M
  • FSS 328.2K
  • Earning Date
  • BBIO 11-11-2025
  • FSS 10-30-2025
  • Dividend Yield
  • BBIO N/A
  • FSS 0.44%
  • EPS Growth
  • BBIO N/A
  • FSS 9.46
  • EPS
  • BBIO N/A
  • FSS 3.59
  • Revenue
  • BBIO $235,812,000.00
  • FSS $1,974,600,000.00
  • Revenue This Year
  • BBIO $115.49
  • FSS $14.48
  • Revenue Next Year
  • BBIO $64.61
  • FSS $7.51
  • P/E Ratio
  • BBIO N/A
  • FSS $35.12
  • Revenue Growth
  • BBIO 7.62
  • FSS 9.09
  • 52 Week Low
  • BBIO $21.72
  • FSS $66.47
  • 52 Week High
  • BBIO $54.60
  • FSS $130.30
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 52.92
  • FSS 54.39
  • Support Level
  • BBIO $52.20
  • FSS $121.86
  • Resistance Level
  • BBIO $54.60
  • FSS $128.37
  • Average True Range (ATR)
  • BBIO 2.26
  • FSS 2.44
  • MACD
  • BBIO -0.06
  • FSS -0.45
  • Stochastic Oscillator
  • BBIO 56.48
  • FSS 61.50

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About FSS Federal Signal Corporation

Federal Signal Corp designs and manufactures products and integrated solutions for municipal, governmental, industrial, and airport customers. It operates in the segments of Environmental Solutions Group and the Safety and Security Systems Group. The Environmental Solutions group manufactures and supplies street sweeper vehicles, sewer cleaner and vacuum loader trucks, hydro-excavation trucks, high-performance water blasting equipment, dump truck bodies, and trailers. The Safety and Security Systems Group offers comprehensive systems and products such as campus and community alerting, emergency vehicles, first responder interoperable communications, and others. The company generates a majority of its revenue from the Environmental Solutions Group segment.

Share on Social Networks: